Association Between DPP-4 Inhibitors and Events of Colorectal and Liver Cancers in Patients With Diabetes Receiving Second-Line Agents: A Nested Case-Control Study

ObjectivePlasma dipeptidyl peptidase-4 (DPP4) levels were significantly lower in patients with colorectal and liver cancers, and animal studies also showed DPP4 inhibitors (DPP4is) have procarcinogenic effects in colorectal cancer. Until now, whether DPP4is therapy affects the progression of liver c...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Chu-Lin Chou, Shu-Hui Juan, Ching-Hao Li, Hsi-Hsien Chen, Chih-Chin Kao, Li-Ying Chen, Li-Nien Chien, Te-Chao Fang
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Frontiers Media S.A. 2022-05-01
Seri Bilgileri:Frontiers in Oncology
Konular:
DPP-4 inhibitors
colorectal cancer
liver cancer
second-line agents
type 2 diabetes mellitus
Online Erişim:https://www.frontiersin.org/articles/10.3389/fonc.2022.840142/full
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller